BUY ABBV — bench-signals (2026-03-20, 4.88 shares @ $204.75)

Desk Move

BUY ABBV — bench-signals (2026-03-20, 4.88 shares @ $204.75)

Summary

AbbVie dividend aristocrat RSI 27.6, Skyrizi/Rinvoq replacing Humira. Historically rare extreme for quality. 5%+ yield. Key support .

Bought 4.88 shares at $204.75.

9 events

No direct external sources are attached to this read.